Literature DB >> 11823278

Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.

Christopher H van Dyck1, Donald M Quinlan, Lisa M Cretella, Julie K Staley, Robert T Malison, Ronald M Baldwin, John P Seibyl, Robert B Innis.   

Abstract

OBJECTIVE: The authors examined whether patients with attention deficit hyperactivity disorder (ADHD) have altered striatal dopamine transporter levels, which may explain psychostimulant effects in this disorder.
METHOD: Single photon emission computed tomography and [(123)I]2beta-carbomethoxy-3beta-(4-iodophenyl)tropane ([(123)I]beta-CIT) were used to assess dopamine transporter availability in nine adult patients with ADHD (eight of whom were stimulant naive) and nine age- and gender-matched healthy comparison subjects.
RESULTS: Striatal [(123)I]beta-CIT binding did not differ significantly between the ADHD and comparison subjects.
CONCLUSIONS: The findings suggest that a hypothesized dysregulation of dopamine function in ADHD does not entail altered dopamine transporter levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823278     DOI: 10.1176/appi.ajp.159.2.309

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  23 in total

Review 1.  ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.

Authors:  Scott H Kollins; R Alison Adcock
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-02-18       Impact factor: 5.067

2.  The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.

Authors:  Amy F T Arnsten
Journal:  J Pediatr       Date:  2009-05-01       Impact factor: 4.406

Review 3.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

4.  Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.

Authors:  Johanna Krause; Christian la Fougere; Klaus-Henning Krause; Manfred Ackenheil; Stefan H Dresel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-08-17       Impact factor: 5.270

5.  Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.

Authors:  Susan E Best; Philip M Sarrel; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; John P Seibyl; Robert B Innis; Christopher H van Dyck
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

6.  Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.

Authors:  Thomas J Spencer; Joseph Biederman; Stephen V Faraone; Bertha K Madras; Ali A Bonab; Darin D Dougherty; Holly Batchelder; Allison Clarke; Alan J Fischman
Journal:  Biol Psychiatry       Date:  2012-12-27       Impact factor: 13.382

Review 7.  The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder.

Authors:  Stephen V Faraone
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

8.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 9.  PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.

Authors:  Patrick Emond; Denis Guilloteau; Sylvie Chalon
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

10.  Evaluating dopamine reward pathway in ADHD: clinical implications.

Authors:  Nora D Volkow; Gene-Jack Wang; Scott H Kollins; Tim L Wigal; Jeffrey H Newcorn; Frank Telang; Joanna S Fowler; Wei Zhu; Jean Logan; Yeming Ma; Kith Pradhan; Christopher Wong; James M Swanson
Journal:  JAMA       Date:  2009-09-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.